Clinical Trial Update: Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on compliance and acceptance of teriparatide injection in severely osteoporotic patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Forteo (Teriparatide) (Teriparatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED